DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Hodi FS, Hwu WJ, Kefford R. et al.
Evaluation of immune-related response criteria and RECIST v1.1 in patients with advanced melanoma treated with pembrolizumab.
J Clin Oncol 2016;
34 (13) 1510-1517
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.